Vaccine protects against Ebola virusBMJ 2000; 321 doi: https://doi.org/10.1136/bmj.321.7274.1433/a (Published 09 December 2000) Cite this as: BMJ 2000;321:1433
- Deborah Josefson
- New York
Researchers have successfully vaccinated macque monkeys against the Ebola virus, inducing full protection against this fatal infection and inspiring hope that a human vaccine will soon follow (Nature 2000;408:605-9).
Ebola virus mysteriously appeared in Sudan and Zaire (formerly the Congo) in 1976, causing haemorrhagic fevers and rapidly killing up to 90% of those infected. The virus has caused periodic outbreaks in Africa ever since. An epidemic currently affecting the northern Gulu district of Uganda has so far killed 140 people.
Ebola belongs to the family of single stranded RNA viruses known as filoviruses and causes haemorrhagic fevers with high mortality. Its natural host is unknown, but a simian reservoir is suspected.
The virus is transmitted …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial